BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Acetaminophen
,
rs2230926
,
BRCA1
,
Allergy to pollen
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
npm1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Gene expression profiling of CEBPA double and single mutant and CEBPA WT AML
Acute myeloid leukemia OCI-AML2 or OCI-AML3 cells treated with DOT1L inhibitor EPZ4777
Acute myeloid leukemia resistance to inhibitor of apoptosis protein antagonist BV6
Acute myeloid leukemia - PBMC gene expression profiles of BCOR mutant and wildtype samples
Explore Curated Studies Results
Literature
Most Relevant Literature
Transplant in AML: just follow the NPM1 guide
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a hete…
NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions.
NPM1-mutated AML: how many diseases?
The discovery of NPM1 mutations in acute myeloid leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daun…
MRD-guided Treatment in NPM1mut AML Patients
A Study of JNJ-75276617 in Participants With Acute Leukemia
Immunophenotyping and Xist Gene in AML
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ